U S PHYSICAL THERAPY INC /NV Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
U S PHYSICAL THERAPY INC /NV (USPH) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $18.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $18.99M, a 24.94% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $16.44M, a 52.87% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $14.72M, a 63.33% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $13.51M, a 35.87% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $54.19M, a 23.38% decline from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $70.73M, a 95.04% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $36.26M, a 10.46% decline from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $40.50M, a 12.12% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18.99M 10-Q · filed 2026-08-07 | $35.43M 10-Q · filed 2026-08-07 | $50.16M derived: sum of 3 quarters · filed 2026-08-07 | $63.67M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $16.44M 10-Q · filed 2026-05-08 | $31.17M derived: sum of 2 quarters · filed 2026-05-08 | $44.68M derived: sum of 3 quarters · filed 2026-05-08 | $59.88M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $14.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $28.24M derived: sum of 2 quarters · filed 2026-02-27 | $43.44M derived: sum of 3 quarters · filed 2026-08-07 | $54.19M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $13.51M 10-Q · filed 2025-11-07 | $28.71M derived: sum of 2 quarters · filed 2026-08-07 | $39.47M 10-Q · filed 2025-11-07 | $79.62M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $15.20M 10-Q · filed 2026-08-07 | $25.95M 10-Q · filed 2026-08-07 | $66.11M derived: sum of 3 quarters · filed 2026-08-07 | $76.06M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $10.76M 10-Q · filed 2026-05-08 | $50.91M derived: sum of 2 quarters · filed 2026-05-08 | $60.86M derived: sum of 3 quarters · filed 2026-05-08 | $73.76M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $40.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $50.10M derived: sum of 2 quarters · filed 2026-02-27 | $63.00M derived: sum of 3 quarters · filed 2026-02-27 | $70.73M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $9.95M 10-Q · filed 2025-11-07 | $22.85M derived: sum of 2 quarters · filed 2025-11-07 | $30.57M 10-Q · filed 2025-11-07 | $40.43M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $12.90M 10-Q · filed 2025-08-08 | $20.63M 10-Q · filed 2025-08-08 | $30.48M derived: sum of 3 quarters · filed 2026-02-27 | $40.67M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $7.73M 10-Q · filed 2025-05-09 | $17.58M derived: sum of 2 quarters · filed 2026-02-27 | $27.77M derived: sum of 3 quarters · filed 2026-02-27 | $37.71M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $9.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.05M derived: sum of 2 quarters · filed 2026-02-27 | $29.98M derived: sum of 3 quarters · filed 2026-02-27 | $36.26M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $10.19M 10-Q · filed 2024-11-08 | $20.13M derived: sum of 2 quarters · filed 2024-11-08 | $26.41M 10-Q · filed 2024-11-08 | $37.29M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $9.94M 10-Q · filed 2024-08-14 | $16.22M 10-Q · filed 2024-08-14 | $27.10M derived: sum of 3 quarters · filed 2025-03-03 | $35.11M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $6.28M 10-Q · filed 2024-05-08 | $17.16M derived: sum of 2 quarters · filed 2025-03-03 | $25.18M derived: sum of 3 quarters · filed 2025-03-03 | $40.77M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $18.89M derived: sum of 2 quarters · filed 2025-03-03 | $34.49M derived: sum of 3 quarters · filed 2025-03-03 | $40.50M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $8.01M 10-Q · filed 2023-11-08 | $23.61M derived: sum of 2 quarters · filed 2023-11-08 | $29.62M 10-Q · filed 2023-11-08 | $41.59M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $15.60M 10-Q · filed 2023-08-09 | $21.61M 10-Q · filed 2023-08-09 | $33.58M derived: sum of 3 quarters · filed 2024-02-29 | $46.85M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $6.01M 10-Q · filed 2023-05-05 | $17.99M derived: sum of 2 quarters · filed 2024-02-29 | $31.26M derived: sum of 3 quarters · filed 2024-02-29 | $44.23M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $25.25M derived: sum of 2 quarters · filed 2024-02-29 | $38.22M derived: sum of 3 quarters · filed 2024-02-29 | $46.09M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $13.27M 10-Q · filed 2022-11-08 | $26.25M derived: sum of 2 quarters · filed 2022-11-08 | $34.11M 10-Q · filed 2022-11-08 | $44.58M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $12.98M 10-Q · filed 2022-08-08 | $20.87M 10-Q · filed 2022-08-08 | $31.32M derived: sum of 3 quarters · filed 2023-02-28 | $34.48M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $7.87M 10-Q · filed 2022-05-09 | $18.34M derived: sum of 2 quarters · filed 2023-02-28 | $21.50M derived: sum of 3 quarters · filed 2023-02-28 | $29.04M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $10.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $13.63M derived: sum of 2 quarters · filed 2023-02-28 | $21.17M derived: sum of 3 quarters · filed 2023-02-28 | $32.71M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $3.16M 10-Q · filed 2021-11-09 | $10.70M derived: sum of 2 quarters · filed 2021-11-09 | $22.24M 10-Q · filed 2021-11-09 | $36.95M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $7.54M 10-Q · filed 2021-08-09 | $19.07M 10-Q · filed 2021-08-09 | $33.78M derived: sum of 3 quarters · filed 2021-08-09 | $42.41M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $11.54M 10-Q · filed 2021-05-10 | $26.25M derived: sum of 2 quarters · filed 2021-05-10 | $34.88M derived: sum of 3 quarters · filed 2021-05-10 | $43.51M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $14.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $23.34M derived: sum of 2 quarters · filed 2021-03-01 | $31.97M derived: sum of 3 quarters · filed 2021-03-01 | $113.22M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | $8.63M 10-Q · filed 2020-11-06 | $6.32M 10-Q · filed 2019-11-08 | $17.26M derived: sum of 2 quarters · filed 2020-11-06 | $98.51M 10-Q · filed 2020-11-06 | $104.83M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $8.63M 10-Q · filed 2020-08-07 | $98.51M 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | $89.89M 10-Q · filed 2020-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |